insights_auto
Zašto je ALMKT pao 8,95%?
Istražite detaljnijechevron_right
ALMKT:EPA
Mauna Kea Technologies SA
0,096 €
arrow_downward
−8,95%(−0,0094) 1D
23. lis, 17:35:21 GMT+2 · EUR
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za ALMKT...
Otvori
0,10 €
Najviša
0,10 €
Najniža
0,09 €
Trž. kap.
18,74 mil.
Prosj. kol.
435,26 tis.
Količina
908,10 tis.
P/E omjer
0,81
52-tjed. najviša
0,23 €
52-tjed. najniža
0,07 €
EPS
0,12 €
Dionice u optjecaju
195,26 mil.
Broj djelatnika
56
Otvori
0,10 €
Najviša
0,10 €
Najniža
0,09 €
Trž. kap.
18,74 mil.
Prosj. kol.
435,26 tis.
Količina
908,10 tis.
P/E omjer
0,81
52-tjed. najviša
0,23 €
52-tjed. najniža
0,07 €
EPS
0,12 €
Dionice u optjecaju
195,26 mil.
Broj djelatnika
56
Vijesti
Iz web-izvora i od partnera za vijesti
Financije.hr
·
prije 1 dan
S&P 500 porastao treći dan zaredom nakon poslovnih rezultata SpaceX-a
Naslovi.net
·
prije 3 dana
Wall Street: Dow skočio za 500 bodova; optimizam oko poslovnih rezultata stabilizirao tržište
Yahoo Finance
·
prije 49 minuta
Elme Communities Announces Suspended NYSE Trading; Anticipates Trading Will Begin OTC Effective October 26, 2026
24/7 Wall St.
·
prije 36 minuta
Wes Moss Says $1 Million in the S&P 500 Pays Just $12,000 a Year in Dividends. Here's His Fix.
Profil
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Mauna Kea Technologies SA – informacije
Glavni izvršni direktorSacha Loiseau
Zaposlenici56
Osnovano2000
Sjedište-
Sektor-
Web-lokacijamaunakeatech.com